Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers.

[1]  A. Popat,et al.  Virus-like Silica Nanoparticles Improve Permeability of Macromolecules across the Blood–Brain Barrier In Vitro , 2023, Pharmaceutics.

[2]  Vicente Martí‐Centelles,et al.  Biosafety of mesoporous silica nanoparticles; towards clinical translation. , 2023, Advanced drug delivery reviews.

[3]  Yunfan Bai,et al.  Virus-like silica nanoparticles enhance macromolecule permeation in vivo. , 2023, Biomaterials science.

[4]  F. Kleitz,et al.  Influence of Pore Size and Surface Functionalization of Mesoporous Silica Nanoparticles on the Solubility and Antioxidant Activity of Confined Coenzyme Q10. , 2023, Molecular pharmaceutics.

[5]  M. Landry,et al.  The protein corona from nanomedicine to environmental science , 2023, Nature Reviews Materials.

[6]  M. Lindén,et al.  Straightforward adsorption-based formulation of mesoporous silia nanoparticles for drug delivery applications. , 2023, Journal of colloid and interface science.

[7]  T. Kohl,et al.  Dissolution control and stability improvement of silica nanoparticles in aqueous media , 2023, Journal of Nanoparticle Research.

[8]  Neetu Singh,et al.  Ultrasmall Silica Nanoparticles in Translational Biomedical Research: Overview and Outlook. , 2022, Advanced drug delivery reviews.

[9]  Tsang-Pai Liu,et al.  Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood–Brain Barrier , 2022, Frontiers in Chemistry.

[10]  A. Duschl,et al.  Surface Functionalization of Silica Nanoparticles: Strategies to Optimize the Immune-Activating Profile of Carrier Platforms , 2022, Pharmaceutics.

[11]  Qiang Sun,et al.  Cationic and Anionic Antimicrobial Agents Co-Templated Mesostructured Silica Nanocomposites with a Spiky Nanotopology and Enhanced Biofilm Inhibition Performance , 2022, Nano-Micro Letters.

[12]  X. Cui,et al.  Noninvasive transdermal delivery of mesoporous silica nanoparticles using deep eutectic solvent. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Jing Su,et al.  Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications. , 2021, Current pharmaceutical design.

[14]  Chengzhong Yu,et al.  Clinical translation of silica nanoparticles , 2021, Nature Reviews Materials.

[15]  M. Lindén,et al.  Dissolution and morphology evolution of mesoporous silica nanoparticles under biologically relevant conditions. , 2021, Journal of colloid and interface science.

[16]  Prarthana V. Rewatkar,et al.  Nanocarriers for oral delivery of biologics: small carriers for big payloads. , 2021, Trends in pharmacological sciences.

[17]  A. Boccaccini,et al.  A shelf-life study of silica- and carbon-based mesoporous materials , 2021 .

[18]  M. Kavallaris,et al.  Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma. , 2021, Nanoscale.

[19]  J. Falconer,et al.  Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin. , 2021, Journal of materials chemistry. B.

[20]  Prarthana V. Rewatkar,et al.  Tacrolimus Encapsulated Mesoporous Silica Nanoparticles Embedded Hydrogel for the Treatment of Atopic Dermatitis. , 2021, International journal of pharmaceutics.

[21]  R. Martínez‐Máñez,et al.  Mesoporous silica nanoparticles for pulmonary drug delivery. , 2021, Advanced drug delivery reviews.

[22]  Song Bai,et al.  Biodegradability of mesoporous silica nanoparticles , 2021, Ceramics International.

[23]  S. Mitragotri,et al.  Nanoparticles in the clinic: An update post COVID‐19 vaccines , 2021, Bioengineering & translational medicine.

[24]  A. Sherje,et al.  ROS responsive mesoporous silica nanoparticles for smart drug delivery: A review , 2021 .

[25]  I. Gadjanski,et al.  Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Ben M. Maoz,et al.  Biology and Models of the Blood-Brain Barrier. , 2021, Annual review of biomedical engineering.

[27]  R. Martínez‐Máñez,et al.  Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles. A new therapeutic approach for acute lung injury treatment. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Michaelis,et al.  Antimicrobial Peptides: Delivery by Dendritic Mesoporous Silica Nanoparticles Enhances the Antimicrobial Activity of a Napsin‐Derived Peptide Against Intracellular Mycobacterium tuberculosis (Adv. Healthcare Mater. 14/2021) , 2021, Advanced Healthcare Materials.

[29]  Min Zhu,et al.  Mesoporous organosilica nanoparticles: Degradation strategies and application in tumor therapy , 2021, View.

[30]  C. Horejs,et al.  Organ chips, organoids and the animal testing conundrum , 2021, Nature Reviews Materials.

[31]  J. Engblom,et al.  Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics? , 2021, International journal of pharmaceutics.

[32]  Bo Wang,et al.  Cationic chitosan-modified silica nanoparticles for oral delivery of protein vaccine. , 2021, Journal of biomedical materials research. Part A.

[33]  Ali Taghvaie Nakhjiri,et al.  Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review , 2021 .

[34]  J. Gomez-Marquez,et al.  Local development of nanotechnology-based diagnostics , 2021, Nature Nanotechnology.

[35]  Yuqing Su,et al.  Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium. , 2021, ACS applied materials & interfaces.

[36]  Hang-sheng Zheng,et al.  Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells , 2021, Acta Pharmacologica Sinica.

[37]  J. Falconer,et al.  Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery. , 2021, Acta biomaterialia.

[38]  Iqra Aslam,et al.  Pharmaco-Technical Evaluation of Statistically Formulated and Optimized Dual Drug-Loaded Silica Nanoparticles for Improved Antifungal Efficacy and Wound Healing , 2021, ACS omega.

[39]  D. Zhao,et al.  Membrane Interactions of Virus-like Mesoporous Silica Nanoparticles. , 2021, ACS nano.

[40]  M. Zhang,et al.  Designer Anticancer Nanoprodrugs Featuring Self-toxification Activity Realized by Acid-triggered Biodegradation and in situ Fragments Complexation. , 2021, Angewandte Chemie.

[41]  M. Gonen,et al.  Use of Ultrasmall Core-Shell Fluorescent Silica Nanoparticles for Image-Guided Sentinel Lymph Node Biopsy in Head and Neck Melanoma , 2021, JAMA network open.

[42]  Y. Daali,et al.  Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice. , 2021, ACS nano.

[43]  Jingyu Liu,et al.  Efficient transfection and long-term stability of rno-miRNA-26a-5p for osteogenic differentiation by large pore sized mesoporous silica nanoparticles. , 2021, Journal of materials chemistry. B.

[44]  Jingjing Wan,et al.  Large-scale synthesis of fractal silica nanoparticles: understanding the impact of solvents , 2021 .

[45]  X. Lin,et al.  Polymer-grafted hollow mesoporous silica nanoparticles integrated with microneedle patches for glucose-responsive drug delivery , 2021, Frontiers of Materials Science.

[46]  M. Kavallaris,et al.  Frontiers in the treatment of glioblastoma: Past, present and emerging. , 2021, Advanced drug delivery reviews.

[47]  J. Falconer,et al.  Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem. , 2021, ACS biomaterials science & engineering.

[48]  Z. Shao,et al.  Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy , 2021, Advanced science.

[49]  E. Hines,et al.  Rambutan-like silica nanoparticles at tailored particle sizes for plasmid DNA delivery , 2021, Journal of Materials Science.

[50]  Zhigang Wang,et al.  Visualized podocyte-targeting and focused ultrasound responsive glucocorticoid nano-delivery system against immune-associated nephropathy without glucocorticoid side effect , 2021, Theranostics.

[51]  F. Tzompantzi,et al.  Mesoporous silica nanoparticles functionalized with folic acid for targeted release Cis-Pt to glioblastoma cells , 2021 .

[52]  N. Voelcker,et al.  Risk assessment on-a-chip: a cell-based microfluidic device for immunotoxicity screening , 2020, Nanoscale advances.

[53]  Turkan Kopac,et al.  Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review. , 2020, International journal of biological macromolecules.

[54]  Chengzhong Yu,et al.  Large scale synthesis of self-assembled shuttlecock-shaped silica nanoparticles with minimized drag as advanced catalytic nanomotors , 2020 .

[55]  F. Kleitz,et al.  On the importance of the linking chemistry for the PEGylation of mesoporous silica nanoparticles. , 2020, Journal of colloid and interface science.

[56]  V. Khutoryanskiy,et al.  Thiolated and PEGylated silica nanoparticle delivery to hair follicles. , 2020, International journal of pharmaceutics.

[57]  M. Chorilli,et al.  Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration , 2020 .

[58]  F. Kleitz,et al.  Irreversible Adsorption of Serum Proteins onto Nanoparticles , 2020, Particle & particle systems characterization.

[59]  A. Alshamsan,et al.  The Design of Anionic Surfactant-Based Amino-Functionalized Mesoporous Silica Nanoparticles and their Application in Transdermal Drug Delivery , 2020, Pharmaceutics.

[60]  H. Lindberg,et al.  Short-term oral administration of non-porous and mesoporous silica did not induce local or systemic toxicity in mice , 2020, Nanotoxicology.

[61]  H. Santos,et al.  One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease , 2020 .

[62]  S. Rössner,et al.  Oral intake of mesoporous silica is safe and well tolerated in male humans , 2020, PloS one.

[63]  Kimberly S. Butler,et al.  Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications , 2020, Nature Reviews Materials.

[64]  Y. Salinas,et al.  Trends in Degradable Mesoporous Organosilica-Based Nanomaterials for Controlling Drug Delivery: A Mini Review , 2020, Materials.

[65]  Yikun Gao,et al.  Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers. , 2020, Journal of colloid and interface science.

[66]  L. S. Taylor,et al.  Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems. , 2020, Molecular pharmaceutics.

[67]  Shumin Li,et al.  The impact of ethanol and chlorobenzene in the structure regulation of dendritic mesoporous silica nanoparticles , 2020 .

[68]  Shumin Li,et al.  Openwork@Dendritic Mesoporous Silica Nanoparticles for Lactate Depletion and Tumor Microenvironment Regulation. , 2020, Angewandte Chemie.

[69]  Prarthana V. Rewatkar,et al.  Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Thanh Loc Nguyen,et al.  Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine. , 2020, ACS applied materials & interfaces.

[71]  Xiaofang Zhong,et al.  The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency , 2020, Science Advances.

[72]  Chengzhong Yu,et al.  Pristine large pore benzene-bridged mesoporous organosilica nanoparticles as an adjuvant and co-delivery platform for eliciting potent antitumor immunity , 2020 .

[73]  H. Friedrich,et al.  Multiscale Colloidal Assembly of Silica Nanoparticles into Microspheres with Tunable Mesopores , 2020, Advanced Functional Materials.

[74]  George Z Kyzas,et al.  Nanomaterials in Cosmetics: Recent Updates , 2020, Nanomaterials.

[75]  M. Gremião,et al.  Formulating octyl methoxycinnamate in hybrid lipid-silica nanoparticles: An innovative approach for UV skin protection , 2020, Heliyon.

[76]  M. Vallet‐Regí,et al.  Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules , 2020, Pharmaceutics.

[77]  S. Ahadian,et al.  Mesoporous silica rods with cone shaped pores modulate inflammation and deliver BMP-2 for bone regeneration , 2020, Nano Research.

[78]  Changzheng Huang,et al.  Hyaluronidase-Functionalized Silica Nanocarrier for Enhanced Chemo-Immunotherapy through Inducing Immunogenic Cell Death. , 2020, ACS Applied Bio Materials.

[79]  P. Caliceti,et al.  Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of “Stealthy” Nanomaterials , 2020, Frontiers in Bioengineering and Biotechnology.

[80]  V. Niculescu.  Mesoporous Silica Nanoparticles for Bio-Applications , 2020, Frontiers in Materials.

[81]  D. Zhao,et al.  Size and charge dual-transformable mesoporous nanoassemblies for enhanced drug delivery and tumor penetration† , 2020, Chemical science.

[82]  J. Armengaud,et al.  Protein Corona Composition of Silica Nanoparticles in Complex Media: Nanoparticle Size does not Matter , 2020, Nanomaterials.

[83]  Richard Novak,et al.  Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips , 2020, Nature Biomedical Engineering.

[84]  C. Duvall,et al.  Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy. , 2020, ACS applied materials & interfaces.

[85]  C. J. Moore,et al.  Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications , 2020, Cancer Nanotechnology.

[86]  Solmaz Maleki Dizaj,et al.  Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae , 2020, Artificial cells, nanomedicine, and biotechnology.

[87]  Chengzhong Yu,et al.  DNA Vaccine Mediated by Rambutan‐Like Mesoporous Silica Nanoparticles , 2020 .

[88]  M. V. Lozano,et al.  The role of the intestinal-protein corona on the mucodiffusion behaviour of new nanoemulsions stabilised by ascorbyl derivatives. , 2019, Colloids and surfaces. B, Biointerfaces.

[89]  M. Montazeri,et al.  Enhanced topical econazole antifungal efficacy by amine-functionalized silica nanoparticles , 2019, Bulletin of Materials Science.

[90]  Chun Xu,et al.  Enhanced eradication of bacterial biofilms with DNase I-loaded silver-doped mesoporous silica nanoparticles. , 2019, Nanoscale.

[91]  M. McGuckin,et al.  Efficient photoacoustic imaging using indocyanine green (ICG) loaded functionalized mesoporous silica nanoparticles. , 2019, Biomaterials science.

[92]  Adrian Berger,et al.  Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability , 2019, Nature Biomedical Engineering.

[93]  Feng Chen,et al.  Ultrasmall Renally-clearable Silica Nanoparticles Target Prostate Cancer. , 2019, ACS applied materials & interfaces.

[94]  Duckshin Park,et al.  Recent Trends of Sunscreen Cosmetic: An Update Review , 2019, Cosmetics.

[95]  Siheng Li,et al.  Boosting antibacterial activity with mesoporous silica nanoparticles supported silver nanoclusters. , 2019, Journal of colloid and interface science.

[96]  V. N. Paunov,et al.  "Ghost" Silica Nanoparticles of "Host"-Inherited Antibacterial Action. , 2019, ACS applied materials & interfaces.

[97]  J. Batra,et al.  Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy , 2019, Front. Bioeng. Biotechnol..

[98]  Samir Mitragotri,et al.  Nanoparticles in the clinic: An update , 2019, Bioengineering & translational medicine.

[99]  Jon A. Schwartz,et al.  Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study , 2019, Proceedings of the National Academy of Sciences.

[100]  A. Ali,et al.  Multidisciplinary Role of Mesoporous Silica Nanoparticles in Brain Regeneration and Cancers: From Crossing the Blood–Brain Barrier to Treatment , 2019, Particle & Particle Systems Characterization.

[101]  B. Sarmento,et al.  Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide , 2019, Pharmaceutics.

[102]  Weisi Guo,et al.  Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides. , 2019, Biomaterials science.

[103]  M. Alonso,et al.  Oral Delivery of Biologics for Precision Medicine , 2019, Advanced materials.

[104]  H. Ghandehari,et al.  Subchronic toxicity of silica nanoparticles as a function of size and porosity. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[105]  T. Bein,et al.  Degradable Drug Carriers: Vanishing Mesoporous Silica Nanoparticles , 2019, Chemistry of Materials.

[106]  Francesca Baldelli Bombelli,et al.  Oral delivery of nanoparticles - let’s not forget about the protein corona , 2019, Expert opinion on drug delivery.

[107]  Xue Shen,et al.  Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. , 2019, Acta biomaterialia.

[108]  Jingying Liu,et al.  Digestive Enzyme Corona Formed in the Gastrointestinal Tract and Its Impact on Epithelial Cell Uptake of Nanoparticles. , 2019, Biomacromolecules.

[109]  Mingxiong Sheng,et al.  Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. , 2019, Colloids and surfaces. B, Biointerfaces.

[110]  Hyo-Jick Choi,et al.  Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals , 2019, Pharmaceutics.

[111]  B. Robertson,et al.  Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles , 2019, PloS one.

[112]  Zhengping Xu,et al.  Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis , 2019, Cell Death & Disease.

[113]  Oliver T. Bruns,et al.  Shortwave infrared imaging with J-aggregates stabilized in hollow mesoporous silica nanoparticles. , 2018, Journal of the American Chemical Society.

[114]  Alessandra Nigro,et al.  Dealing with Skin and Blood-Brain Barriers: The Unconventional Challenges of Mesoporous Silica Nanoparticles , 2018, Pharmaceutics.

[115]  T. Coradin,et al.  Collagen-silica nanocomposites as dermal dressings preventing infection in vivo. , 2018, Materials science & engineering. C, Materials for biological applications.

[116]  C. Brinker,et al.  Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics , 2018, Nature Communications.

[117]  S. D. Kinrade,et al.  Non-Functionalized Ultrasmall Silica Nanoparticles Directly and Size-Selectively Activate T Cells. , 2018, ACS nano.

[118]  K. Paknikar,et al.  Mesoporous silica nanoparticles as cutting‐edge theranostics: Advancement from merely a carrier to tailor‐made smart delivery platform , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[119]  H. Maibach,et al.  Mesoporous silica nanoparticles for enhanced lidocaine skin delivery , 2018, International journal of pharmaceutics.

[120]  Edmund J. Crampin,et al.  Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.

[121]  Jie Zheng,et al.  Transport and interactions of nanoparticles in the kidneys , 2018, Nature Reviews Materials.

[122]  Milica Radisic,et al.  Advances in organ-on-a-chip engineering , 2018, Nature Reviews Materials.

[123]  F. Caruso,et al.  Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases , 2018, Advanced materials.

[124]  V. G. Pangarkar,et al.  Development of Doxorubicin-Loaded Magnetic Silica–Pluronic F-127 Nanocarriers Conjugated with Transferrin for Treating Glioblastoma across the Blood–Brain Barrier Using an in Vitro Model , 2018, ACS omega.

[125]  Shenda Gu,et al.  Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery , 2018, International journal of nanomedicine.

[126]  P. Doerschuk,et al.  Self-assembly of highly symmetrical, ultrasmall inorganic cages directed by surfactant micelles , 2018, Nature.

[127]  Xin Du,et al.  Disulfide‐Bridged Organosilica Frameworks: Designed, Synthesis, Redox‐Triggered Biodegradation, and Nanobiomedical Applications , 2018 .

[128]  Alke Petri-Fink,et al.  Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials , 2018, Advanced materials.

[129]  J. Jeong,et al.  Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy , 2018, ACS central science.

[130]  Gang Liu,et al.  Imaging Nano-Bio Interactions in the Kidney: Toward a Better Understanding of Nanoparticle Clearance. , 2018, Angewandte Chemie.

[131]  Chengzhong Yu,et al.  Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses. , 2018, Chemical communications.

[132]  A. Allen.  The Structure and Function of Gastrointestinal Mucus , 2018 .

[133]  M. Vallet‐Regí,et al.  Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights , 2017, Molecules.

[134]  R. Chuck,et al.  Safety of Nonporous Silica Nanoparticles in Human Corneal Endothelial Cells , 2017, Scientific Reports.

[135]  F. Kleitz,et al.  Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. , 2017, Nanoscale.

[136]  F. Calon,et al.  Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting. , 2017, Journal of materials chemistry. B.

[137]  S. Sapino,et al.  Mesoporous silica nanoparticles as a promising skin delivery system for methotrexate. , 2017, International journal of pharmaceutics.

[138]  Hongwei Zhang,et al.  Glucose-Responsive Nanosystem Mimicking the Physiological Insulin Secretion via an Enzyme–Polymer Layer-by-Layer Coating Strategy , 2017 .

[139]  M. Schwaiger,et al.  Exploring the Role of RGD-Recognizing Integrins in Cancer , 2017, Cancers.

[140]  Rongqin Huang,et al.  An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma. , 2017, Nanoscale.

[141]  J. Brieger,et al.  Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer , 2017, Nanomaterials.

[142]  A. Kharlamov,et al.  Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial. , 2017, Future cardiology.

[143]  Yang Song,et al.  In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier. , 2017, ACS applied materials & interfaces.

[144]  L. Godderis,et al.  Toxicology of silica nanoparticles: an update , 2017, Archives of Toxicology.

[145]  W. Tremel,et al.  Dendritic Mesoporous Silica Nanoparticles for pH‐Stimuli‐Responsive Drug Delivery of TNF‐Alpha , 2017, Advanced healthcare materials.

[146]  Lin Mei,et al.  pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy. , 2017, ACS applied materials & interfaces.

[147]  Suk-Jo Kang,et al.  Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4. , 2017, Nano letters.

[148]  N. Khashab,et al.  Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles , 2017, Advanced materials.

[149]  Byron Ballou,et al.  Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules , 2017, Proceedings of the National Academy of Sciences.

[150]  Volker Rasche,et al.  Cargo-influences on the biodistribution of hollow mesoporous silica nanoparticles as studied by quantitative 19F-magnetic resonance imaging. , 2017, Journal of colloid and interface science.

[151]  Wei Zhang,et al.  Dual Functional Mesoporous Silicon Nanoparticles Enhance the Radiosensitivity of VPA in Glioblastoma1 , 2017, Translational oncology.

[152]  J. Hamman,et al.  In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration , 2017, Expert opinion on drug delivery.

[153]  I. Correia,et al.  Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: A review , 2016 .

[154]  B. Bugarski,et al.  Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[155]  P. Leung,et al.  Cellular Interactions and Formation of an Epithelial “Nanocoating-Like Barrier” with Mesoporous Silica Nanoparticles , 2016, Nanomaterials.

[156]  Claudia Fruijtier-Pölloth.  The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551) , 2016, Archives of Toxicology.

[157]  T. Trindade,et al.  The Role of Surface Functionalization of Silica Nanoparticles for Bioimaging , 2016 .

[158]  R. C.-Gaudreault,et al.  Size-Controlled Functionalized Mesoporous Silica Nanoparticles for Tunable Drug Release and Enhanced Anti-Tumoral Activity , 2016 .

[159]  Xin Du,et al.  Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. , 2016, Biomaterials.

[160]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[161]  Jens Gruber,et al.  Dissolution kinetics of mesoporous silica nanoparticles in different simulated body fluids , 2016, Journal of Sol-Gel Science and Technology.

[162]  Chengzhong Yu,et al.  Small-sized and large-pore dendritic mesoporous silica nanoparticles enhance antimicrobial enzyme delivery. , 2016, Journal of materials chemistry. B.

[163]  Tianfeng Chen,et al.  Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier. , 2016, ACS applied materials & interfaces.

[164]  S. Mitragotri,et al.  Nanoparticles in the clinic , 2016, Bioengineering & translational medicine.

[165]  S. Sen,et al.  Silicosis in Current Scenario: A Review of Literature , 2016 .

[166]  Ulrich B Wiesner,et al.  Elucidating the Mechanism of Silica Nanoparticle PEGylation Processes Using Fluorescence Correlation Spectroscopies , 2016 .

[167]  M. Roberts,et al.  Short- and Long-Term Tracking of Anionic Ultrasmall Nanoparticles in Kidney. , 2016, ACS nano.

[168]  Linlin Li,et al.  Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[169]  Y. Won,et al.  Effects of nanoparticles on the mechanical functioning of the lung. , 2015, Advances in colloid and interface science.

[170]  A. Dinda,et al.  Organically Modified Silica Nanoparticles Interaction with Macrophage Cells: Assessment of Cell Viability on the Basis of Physicochemical Properties. , 2015, Journal of pharmaceutical sciences.

[171]  Jay West,et al.  Comparative assessment of nanomaterial definitions and safety evaluation considerations. , 2015, Regulatory toxicology and pharmacology : RTP.

[172]  Hongwei Zhang,et al.  Core-Cone Structured Monodispersed Mesoporous Silica Nanoparticles with Ultra-large Cavity for Protein Delivery. , 2015, Small.

[173]  T. Bein,et al.  Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery. , 2015, Nanoscale.

[174]  H. M. Nielsen,et al.  Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[175]  Kangtaek Lee,et al.  Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics , 2015, Experimental & Molecular Medicine.

[176]  Hongwei Zhang,et al.  Biphasic Synthesis of Large-Pore and Well-Dispersed Benzene Bridged Mesoporous Organosilica Nanoparticles for Intracellular Protein Delivery. , 2015, Small.

[177]  Samir Mitragotri,et al.  A Review of Clinical Translation of Inorganic Nanoparticles , 2015, The AAPS Journal.

[178]  A. Kharlamov,et al.  Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. , 2015, Nanoscale.

[179]  C. J. Moore,et al.  Controlling colloidal stability of silica nanoparticles during bioconjugation reactions with proteins and improving their longer-term stability, handling and storage. , 2015, Journal of materials chemistry. B.

[180]  C. Fong.  Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds , 2015, The Journal of Membrane Biology.

[181]  R. Lecomte,et al.  Metal chelate grafting at the surface of mesoporous silica nanoparticles (MSNs): physico-chemical and biomedical imaging assessment. , 2015, Journal of materials chemistry. B.

[182]  Feng Chen,et al.  Nanomedicine for targeted photothermal cancer therapy: where are we now? , 2015, Nanomedicine.

[183]  B. Lee,et al.  Toxicity of colloidal silica nanoparticles administered orally for 90 days in rats , 2014, International journal of nanomedicine.

[184]  M. Gremião,et al.  Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies. , 2014, Colloids and surfaces. B, Biointerfaces.

[185]  Mithat Gönen,et al.  Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.

[186]  Chengzhong Yu,et al.  Nanodispersed UV blockers in skin-friendly silica vesicles with superior UV-attenuating efficiency. , 2014, Journal of materials chemistry. B.

[187]  R. C.-Gaudreault,et al.  Mesoporous Silica Nanoparticles: Selective Surface Functionalization for Optimal Relaxometric and Drug Loading Performances , 2014 .

[188]  Xian‐Zheng Zhang,et al.  Multifunctional Enveloped Mesoporous Silica Nanoparticles for Subcellular Co-delivery of Drug and Therapeutic Peptide , 2014, Scientific Reports.

[189]  Carlos A. Muniesa,et al.  Effect of surface properties in protein corona development on mesoporous silica nanoparticles , 2014 .

[190]  C. Prestidge,et al.  First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen , 2014, Drug Delivery and Translational Research.

[191]  G. Mainelis,et al.  Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention , 2014, Cancer biology & medicine.

[192]  Zhi Zhu,et al.  In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. , 2014, ACS applied materials & interfaces.

[193]  Xian‐Zheng Zhang,et al.  A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery. , 2014, Small.

[194]  W. Li,et al.  Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. , 2014, Nano letters.

[195]  D. Zhao,et al.  Ordered Mesoporous Materials Based on Interfacial Assembly and Engineering , 2013 .

[196]  Chi-Hwa Wang,et al.  Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. , 2013, Biomaterials.

[197]  Xin Du,et al.  Developing Functionalized Dendrimer‐Like Silica Nanoparticles with Hierarchical Pores as Advanced Delivery Nanocarriers , 2013, Advanced materials.

[198]  Hao Wang,et al.  Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells. , 2013, ACS applied materials & interfaces.

[199]  Jianlin Shi,et al.  In Vivo Bio‐Safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles , 2013, Advanced materials.

[200]  Cecilia Sahlgren,et al.  Mesoporous silica nanoparticles in medicine--recent advances. , 2013, Advanced drug delivery reviews.

[201]  M. Johansson,et al.  The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[202]  L. Tang,et al.  Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates. , 2013, Molecular pharmaceutics.

[203]  Andrzej S Pitek,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[204]  Evan Phillips,et al.  Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[205]  M. Lag,et al.  Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages , 2012, Particle and Fibre Toxicology.

[206]  Linlin Li,et al.  In vitro degradation behavior of silica nanoparticles under physiological conditions. , 2012, Journal of nanoscience and nanotechnology.

[207]  Jürgen Lademann,et al.  Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. , 2012, ACS nano.

[208]  Chengzhong Yu,et al.  A simple approach to prepare monodisperse mesoporous silica nanospheres with adjustable sizes. , 2012, Journal of colloid and interface science.

[209]  Piper J. Klemm,et al.  Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents. , 2012, Journal of the American Chemical Society.

[210]  Dongyun Chen,et al.  Hollow mesoporous silica nanoparticles conjugated with pH-sensitive amphiphilic diblock polymer for controlled drug release , 2012 .

[211]  Jan Tack,et al.  The migrating motor complex: control mechanisms and its role in health and disease , 2012, Nature Reviews Gastroenterology &Hepatology.

[212]  Zongxi Li,et al.  Mesoporous silica nanoparticles in biomedical applications. , 2012, Chemical Society reviews.

[213]  T. Minko,et al.  Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA , 2011, Journal of drug targeting.

[214]  H. Bouwmeester,et al.  Presence and risks of nanosilica in food products , 2011, Nanotoxicology.

[215]  Q. Tao,et al.  Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. , 2011, Nanoscale.

[216]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[217]  Wolfgang Becker,et al.  Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.

[218]  Monya Baker,et al.  Tissue models: A living system on a chip , 2011, Nature.

[219]  Dora Brites,et al.  Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.

[220]  Y. S. Kim,et al.  Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress , 2010, Current gastroenterology reports.

[221]  T. Bein,et al.  Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol) , 2010 .

[222]  Chin-Tu Chen,et al.  Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.

[223]  Ling Ye,et al.  The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain. , 2010, Biochemical and biophysical research communications.

[224]  M. Jaroniec.  Silicon beyond the valley. , 2009, Nature Chemistry.

[225]  M. Schoenfisch,et al.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. , 2009, Biomaterials.

[226]  Laetitia Gonzalez,et al.  Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.

[227]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[228]  M. McGuckin,et al.  Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.

[229]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[230]  K. Martin,et al.  The chemistry of silica and its potential health benefits. , 2007, The journal of nutrition, health & aging.

[231]  R. Jugdaohsingh,et al.  Silicon and bone health. , 2007, The journal of nutrition, health & aging.

[232]  Deng-Fwu Hwang,et al.  In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. , 2007, Environmental science & technology.

[233]  Justin Hanes,et al.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.

[234]  Zhivko Zhelev,et al.  Single quantum dot-micelles coated with silica shell as potentially non-cytotoxic fluorescent cell tracers. , 2006, Journal of the American Chemical Society.

[235]  N. Smorodinsky,et al.  The MUC1 SEA Module Is a Self-cleaving Domain* , 2005, Journal of Biological Chemistry.

[236]  J. Powell,et al.  Dietary silicon and bone health , 2005 .

[237]  M. Hollingsworth,et al.  The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane‐tethered mucins , 2005, The FEBS journal.

[238]  M. Vallet‐Regí,et al.  Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .

[239]  Jacques Devière,et al.  Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. , 2004, Gastroenterology.

[240]  Weihong Tan,et al.  Development of Organic‐Dye‐Doped Silica Nanoparticles in a Reverse Microemulsion , 2004 .

[241]  D. Zhao,et al.  Cubic mesoporous silica with large controllable entrance sizes and advanced adsorption properties. , 2003, Angewandte Chemie.

[242]  Victor S-Y Lin,et al.  A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.

[243]  Gopinathan K Menon,et al.  New insights into skin structure: scratching the surface. , 2002, Advanced drug delivery reviews.

[244]  W. Pardridge,et al.  Rapid transferrin efflux from brain to blood across the blood–brain barrier , 2001, Journal of neurochemistry.

[245]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[246]  G. Ozin,et al.  Periodic mesoporous organosilicas with organic groups inside the channel walls , 1999, Nature.

[247]  Galen D. Stucky,et al.  MESOPOROUS SILICATE SEQUESTRATION AND RELEASE OF PROTEINS , 1999 .

[248]  B. J. Melde,et al.  Mesoporous sieves with unified hybrid inorganic/organic frameworks , 1999 .

[249]  T. Ohsuna,et al.  Novel Mesoporous Materials with a Uniform Distribution of Organic Groups and Inorganic Oxide in Their Frameworks , 1999 .

[250]  Fredrickson,et al.  Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores , 1998, Science.

[251]  J. B. Higgins,et al.  A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .

[252]  L. Hunsicker,et al.  Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. , 1985, Kidney international.

[253]  Jaeyun Kim,et al.  Functional mesoporous silica nanoparticles for bio-imaging applications. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[254]  Srinivasan Vijayakumar,et al.  Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy. , 2013, Practical radiation oncology.

[255]  Michelle Bradbury,et al.  Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. , 2009, Nano letters.

[256]  J. Ying,et al.  Generalized fluorocarbon-surfactant-mediated synthesis of nanoparticles with various mesoporous structures. , 2004, Angewandte Chemie.

[257]  D. Warheit,et al.  Inhaled amorphous silica particulates: what do we know about their toxicological profiles? , 2001, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[258]  K. Unger,et al.  The use of porous and surface modified silicas as drug delivery and stabilizing agents , 1983 .

[259]  B. Brenner,et al.  Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. , 1978, The Journal of clinical investigation.

[260]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .